Clinical Trial Update: BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing BIRB 796 BS to placebo in moderate-to-severe plaque-type psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BIRB 796 BS (BIRB 796)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Psoriasis | Phase 2 | Status: COMPLETED